| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0959-437X(00)00228-8 |
| P698 | PubMed publication ID | 11532394 |
| P50 | author | Erwin F. Wagner | Q40012298 |
| P2093 | author name string | G Karsenty | |
| P2860 | cites work | Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. | Q52537176 |
| Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation | Q57675158 | ||
| Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 | Q57675161 | ||
| Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation | Q58085524 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 | ||
| Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse Osteocalcin promoters | Q73066690 | ||
| The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants | Q73531419 | ||
| Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 | ||
| Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia | Q24309601 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation | Q24600279 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes | Q24628843 | ||
| Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase | Q28137640 | ||
| Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein | Q28137935 | ||
| Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis | Q28140437 | ||
| Negative regulation of BMP/Smad signaling by Tob in osteoblasts | Q28143428 | ||
| Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis | Q28143618 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man | Q28201425 | ||
| Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation | Q28240596 | ||
| Bone: formation by autoinduction | Q28251545 | ||
| Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein | Q28281538 | ||
| Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass | Q28505908 | ||
| PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth | Q28506149 | ||
| Maturational disturbance of chondrocytes in Cbfa1-deficient mice | Q28506259 | ||
| Regulation of chondrocyte differentiation by Cbfa1 | Q28509820 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Sox9 is required for cartilage formation | Q28588649 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene | Q28590408 | ||
| Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
| Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature | Q30621126 | ||
| FGFs, heparan sulfate and FGFRs: complex interactions essential for development | Q33828280 | ||
| Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. | Q33916614 | ||
| Regulation of the differentiation and function of osteoclasts | Q34010151 | ||
| The osteoblast: a sophisticated fibroblast under central surveillance | Q34021172 | ||
| AP-1 in mouse development and tumorigenesis | Q34279346 | ||
| Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro | Q34459310 | ||
| Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice | Q35076965 | ||
| Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones | Q36316526 | ||
| Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors | Q36375584 | ||
| Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 | ||
| Chondrogenesis just ain't what it used to be. | Q39906724 | ||
| Fra-1 replaces c-Fos-dependent functions in mice | Q40445308 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 | ||
| Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes | Q42934690 | ||
| Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. | Q45345530 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 527-532 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
| P1476 | title | Genetic control of skeletal development | |
| P478 | volume | 11 |
| Q39489640 | 3β-Hydroxysterol-Delta24 reductase plays an important role in long bone growth by protecting chondrocytes from reactive oxygen species |
| Q35586731 | A bit of give and take: the relationship between the extracellular matrix and the developing chondrocyte |
| Q36323606 | A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation |
| Q38322094 | A specific oligodeoxynucleotide promotes the differentiation of osteoblasts via ERK and p38 MAPK pathways |
| Q37374302 | ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae |
| Q39041957 | Achondroplasia: Development, pathogenesis, and therapy. |
| Q42210499 | Adult stem cells properties in terms of commitment, aging and biological safety of grit-blasted and Acid-etched ti dental implants surfaces |
| Q42549696 | Aggrecan is required for growth plate cytoarchitecture and differentiation |
| Q42931803 | Aggrecan modulation of growth plate morphogenesis |
| Q35138548 | Aryl hydrocarbon receptor-mediated down-regulation of sox9b causes jaw malformation in zebrafish embryos |
| Q35007314 | Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass |
| Q36324476 | Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes |
| Q42003155 | Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells |
| Q81659680 | Cbfa1-dependent expression of an interferon-inducible p204 protein is required for chondrocyte differentiation |
| Q39793750 | Cellular morphology and markers of cartilage and bone in the marine teleost Sparus auratus. |
| Q47330729 | Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts |
| Q37286240 | Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation |
| Q38188554 | Current understanding on the molecular basis of chondrogenesis |
| Q91643125 | Daily intake of polyamine-rich Saccharomyces cerevisiae S631 prevents osteoclastic activation and bone loss in ovariectomized mice |
| Q36612109 | Defining structural abnormalities of the hip joint at risk of degeneration |
| Q101468030 | Defining the Critical Period of Hedgehog Pathway Inhibitor-Induced Cranial Base Dysplasia in Mice |
| Q42552589 | Disruption of calvarial ossification in E2f4 mutant embryos correlates with increased proliferation and progenitor cell populations |
| Q28588130 | Dlx5 Is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification |
| Q55230047 | EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation. |
| Q38847179 | Effects of electromagnetic fields on osteoporosis: A systematic literature review |
| Q50448979 | Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation. |
| Q40450496 | Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo. |
| Q88071349 | Extracellular matrix dynamics during mesenchymal stem cells differentiation |
| Q36111408 | FGF signaling in the developing endochondral skeleton |
| Q28505595 | FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate |
| Q39260911 | Focal adhesion kinase/Src suppresses early chondrogenesis: central role of CCN2. |
| Q28235267 | Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development |
| Q34874767 | Formation and function of the ruffled border in osteoclasts |
| Q34963037 | Functions of AP1 (Fos/Jun) in bone development |
| Q37730952 | Functions of nuclear factor kappaB in bone |
| Q47425056 | Genome scan for QTLs underlying bone size variation at 10 refined skeletal sites: genetic heterogeneity and the significance of phenotype refinement |
| Q35802390 | Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritis |
| Q28539657 | Growth factor priming differentially modulates components of the extracellular matrix proteome in chondrocytes and synovium-derived stem cells |
| Q30579948 | Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors |
| Q38944254 | High glucose inhibits receptor activator of nuclear factor‑κB ligand-induced osteoclast differentiation via downregulation of v‑ATPase V0 subunit d2 and dendritic cell‑specific transmembrane protein |
| Q37348836 | Host cell specificity of minute virus of mice in the developing mouse embryo |
| Q41640132 | Icariside II promotes osteogenic differentiation of bone marrow stromal cells in beagle canine |
| Q46931406 | Identification of vitamin D receptor as a target of p63. |
| Q28593802 | Inactivation of Six2 in mouse identifies a novel genetic mechanism controlling development and growth of the cranial base |
| Q29618116 | Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts |
| Q37401772 | Inhibition of osteoblastic bone formation by nuclear factor-kappaB. |
| Q42680295 | Integrated mRNA and microRNA transcriptome analyses reveal regulation of thermal acclimation in Gymnocypris przewalskii: A case study in Tibetan Schizothoracine fish. |
| Q35575324 | MAP kinases in chondrocyte differentiation. |
| Q38641208 | Mandible and Tongue Development |
| Q34994492 | Mechanisms of bone resorption and new bone formation in spondyloarthropathies |
| Q36073894 | Mechanistic insight into osteoclast differentiation in osteoimmunology |
| Q34246045 | Mice Deficient in NF-κB p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism. |
| Q34695969 | Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. |
| Q37516656 | NOTCHing the bone: insights into multi-functionality. |
| Q37177999 | Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. |
| Q38285398 | Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies |
| Q42823527 | Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis |
| Q30482448 | Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis |
| Q29547556 | Osteoclast differentiation and activation |
| Q36803600 | Osteosarcoma development and stem cell differentiation |
| Q51614047 | Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. |
| Q35191578 | PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading |
| Q37161420 | Perichondrial expression of Wdr5 regulates chondrocyte proliferation and differentiation |
| Q38163881 | Polyamine delivery as a tool to modulate stem cell differentiation in skeletal tissue engineering |
| Q34792780 | Primitive adult hematopoietic stem cells can function as osteoblast precursors |
| Q38824534 | Protective effects of casein-derived peptide VLPVPQK against hydrogen peroxide-induced dysfunction and cellular oxidative damage in rat osteoblastic cells |
| Q57675150 | RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β |
| Q24629421 | RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro |
| Q35800463 | RNA therapeutics targeting osteoclast-mediated excessive bone resorption |
| Q34611297 | Reaching a genetic and molecular understanding of skeletal development |
| Q33527391 | Regulation of gene expression by PI3K in mouse growth plate chondrocytes |
| Q38103811 | Regulatory mechanisms for the development of growth plate cartilage |
| Q36794857 | Relationship between joint shape and the development of osteoarthritis |
| Q42828127 | Retinoic acid inhibits osteogenic differentiation of mouse embryonic palate mesenchymal cells |
| Q40598895 | RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. |
| Q33933027 | Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients |
| Q38056632 | Roles of Wnt signals in bone resorption during physiological and pathological states. |
| Q34731222 | Signaling crosstalk between RANKL and interferons in osteoclast differentiation |
| Q35553533 | Signalling in osteoclasts and the role of Fos/AP1 proteins |
| Q33299652 | Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation |
| Q33327777 | The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation |
| Q35831159 | The regulation of osteoclast differentiation by Wnt signals |
| Q33861355 | The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers |
| Q34191657 | The two faces of serotonin in bone biology |
| Q28512237 | Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis |
| Q83177173 | Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation |
| Q93014287 | Vaspin antagonizes high fat-induced bone loss in rats and promotes osteoblastic differentiation in primary rat osteoblasts through Smad-Runx2 signaling pathway |
| Q35083564 | Wdr5 is required for chick skeletal development. |
| Q34156626 | Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB. |
Search more.